IL-6 induces myeloid PD-L1 expression in GBM, and disruption of IL-6 signaling in orthotopic murine glioma models decreased local and peripheral myeloid-mediated immunosuppression and promoted antitumor immunoactivity [33]. The gene discussed is IL6; the disease is central nervous system cancer.